Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
- 22 May 2020
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 79 (8) , 1007-1013
Abstract
Objective The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-19) have not been reported. This study aimed to describe the clinical features of COVID-19 in rheumatic patients and provide information for handling this situation in clinical practice. Methods This is a retrospective case series study. Deidentified data, including gender, age, laboratory and radiological results, symptoms, signs, and medication history, were collected from 2326 patients diagnosed with COVID-19, including 21 cases in combination with rheumatic disease, in Tongji Hospital between 13 January and 15 March 2020. Results Length of hospital stay and mortality rate were similar between rheumatic and non-rheumatic groups, while the presence of respiratory failure was more common in rheumatic cases (38% vs 10%, pConclusions Respiratory failure was more common in rheumatic patients infected with COVID-19. Differential diagnosis between COVID-19 and a flare of rheumatic disease should be considered. Trial registration number ChiCTR2000030795.Keywords
Funding Information
- National Natural Science Foundation of China (81670431, 81771754, 81974254)
- Tongji Hospital Clinical Research Flagship Program (2019CR206)
- Hubei Chen Xiaoping Science and Technology Development Foundation Clinical Research Special Fund (CXPJJH11800005-07)
This publication has 31 references indexed in Scilit:
- Fatigue, Sleep, and Autoimmune and Related DisordersFrontiers in Immunology, 2019
- Gastrointestinal Manifestations of Rheumatological DiseasesAmerican Journal of Gastroenterology, 2019
- The Immune System Computes the State of the Body: Crowd Wisdom, Machine Learning, and Immune Cell Reference Repertoires Help Manage InflammationFrontiers in Immunology, 2019
- Therapeutic Mechanisms of GlucocorticoidsTrends in Endocrinology & Metabolism, 2018
- Tocilizumab (Actemra)Human Vaccines & Immunotherapeutics, 2017
- New insights into the immunopathogenesis of systemic lupus erythematosusNature Reviews Rheumatology, 2016
- Rheumatoid arthritisThe Lancet, 2016
- Management of interstitial lung disease associated with connective tissue diseaseBMJ, 2016
- Advances in understanding the pathogenesis of primary Sjögren's syndromeNature Reviews Rheumatology, 2013
- Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and MethotrexateArchives of internal medicine (1960), 1999